In April, Takeda announced a multi-year, multi-million dollar investment in Xavier University of Louisiana to pursue T-REX, the university’s new center for technical research and exchange that will include health informatics, research findings and interventions to improve health outcomes and well-being.
Xavier University, which will mark its centennial in 2025, is located in New Orleans and is the nation’s only historically Black and Catholic university. In a city and state that for generations has been marked by unequal health care treatment for White and Black patients, Xavier rose to become a national leader in educating the largest number of Black undergraduates who have gone on to become doctors and pharmacists.
The American Journal of Managed Care interviewed Lauren Powell, MPA, PhD, vice president, US Health Equity & Community Wellness at Takeda, and Xavier Provost Anne McCall, PhD, about the partnership. Segments from these interview will appear over the next two weeks; the first segment appears today. An article on the partnership will appear in the August issue of Evidence-Based Oncology, which is a special issue on topics in health equity.
AJMC®: Can you give us an overview of the T-REX initiative that Takeda is undertaking with Xavier University of Louisiana?
Powell: We are so excited about the T-REX initiative that we're pursuing and in partnership, and to support Xavier University of Louisiana. The T-REX initiative is really focused [as] an extension of Xavier's focus on health equity, and really expanding opportunities for students there to further their learning on areas such as health informatics, on leveraging data to achieve health equity, and further opportunities to connect with the community that already has a deep trust for Xavier.
AJMC®: Xavier has been known for decades as a national leader in educating future Black physicians and black pharmacists, and is also a trusted institution in a city where Black Americans (for good reason) have had cause to not trust the medical establishment. How did these factors weigh into educators decision to partner with Xavier?
Powell: Historic mistrust is something that continues to impact Black and Brown communities in particular. We can think about several examples from history as well as even present examples—right now and in real time—that still continue to give communities cause to not trust, the medical establishment in general. And so in thinking about how important our health equity work is here, and one of the very important foundations of our health equity work being around trust, we really wanted to partner with an organization that is seen as very trustworthy by Black and Brown communities. We know that Xavier University of Louisiana is one of those [institutions] that is deeply trusted by the New Orleans community, by the larger Louisiana community, by the Deeper South, and the entire Southern and Gulf Coast region. And we wanted to pursue a partnership with the experts on how to build trust. We see opportunities to learn from failure—and that deeply motivated our desire to want to learn from them and to want to partner with them on this initiative.
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Early Detection Strategies for Interstitial Lung Disease in Rheumatology: Janet Pope, MD, MPH
August 11th 2025Janet Pope, MD, MPH, discusses screening and diagnostic approaches for interstitial lung disease in patients with systemic sclerosis, rheumatoid arthritis, and other connective tissue diseases.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More